1. Preliminary results from two leading vaccine trials show promise  CBS Evening News
  2. Experimental coronavirus vaccine shows promise, progresses to advanced trial  New York Post
  3. Human trials of British coronavirus vaccine to reach 10,000  Reuters
  4. AstraZeneca Is Caught Up in Delicate Vaccine Politics  Bloomberg
  5. Scientists vs politicians: the reality check for ‘warp speed’ vaccine research  Financial Times
  6. View Full coverage on Google News
Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving U.S. backing worth up to $1.2 billion.Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving U.S. backing worth up to $1.2 billion.

Human trials of British coronavirus vaccine to reach 10,000 - Reuters

A team from Oxford University told NBC News that the expanded trial will allow doctors to determine how effective the shot is at preventing COVID-19.A promising experimental vaccine for the coronavirus hit a milestone Friday, with British researchers announcing they will be progressing to advanced stages of human trials. The team from

Coronavirus vaccine shows promise, progresses to advanced trial

Slaoui, an immunologist has already developed 24 vaccines to combat Ebola, malaria and abdominal infections - Anadolu AgencySlaoui, an immunologist has already developed 24 vaccines to combat Ebola, malaria and abdominal infections - Anadolu Agency

Trump’s vaccine chief has a Moroccan background

Bloomberg - Are you a robot?

Poor communication from Jonas Salk and lax regulation led to unecessary suffering in the polio vaccine rush. Trump may be repeating the same mistakes.Poor communication from Jonas Salk and lax regulation led to unecessary suffering in the polio vaccine rush. Trump may be repeating the same mistakes.

Epidemiologist warns: Trump's vaccine push may be dangerous - Los Angeles Times

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“Oxford, AstraZeneca begin advanced trials of Covid vaccine @LauermanJohn reports https://t.co/baA6VZECin”

Shekhar Gupta on Twitter: "Oxford, AstraZeneca begin advanced trials of Covid vaccine @LauermanJohn reports https://t.co/baA6VZECin"

“$JNJ Chinese Covid-19 Vaccine Trial Results Are a Good Sign for J&J and AstraZeneca’s Efforts https://t.co/u2qIOVySFY”

Ophir Gottlieb on Twitter: "$JNJ Chinese Covid-19 Vaccine Trial Results Are a Good Sign for J&J and AstraZeneca’s Efforts https://t.co/u2qIOVySFY"

“US provides AstraZeneca with $1 billion for COVID-19 vaccine #GeoNews”

Geo English on Twitter: "US provides AstraZeneca with $1 billion for COVID-19 vaccine #GeoNews"

Anthony Fauci cautioned Wednesday that using the name 'Operation Warp Speed' to prioritize the initiative to get a vaccine approved for coronavirus could embolden the anti-vaccine movement.Anthony Fauci cautioned Wednesday that using the name 'Operation Warp Speed' to prioritize the initiative to get a vaccine approved for coronavirus could embolden the anti-vaccine movement.

Fauci fears anti-vaxxers will exploit 'Operation Warp Speed' | Daily Mail Online

THE US has purchased around 300 million COVID-19 vaccines from AsteaZeneca.THE US has purchased around 300 million COVID-19 vaccines from AsteaZeneca.

Coronavirus US: 300 million AstraZeneca vaccines bought | World | News | Express.co.uk

An Oxford University team are already mass producing a possible vaccine on an industrial scale before animal and human trials indicate whether it can lead to serious immune systems complications An Oxford University team are already mass producing a possible vaccine on an industrial scale before animal and human trials indicate whether it can lead to serious immune systems complications

Coronavirus vaccine set for early autumn - but scientist warns of deadly risk - Mirror Online

403 Missing Auth Token

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

UK News: LONDON: Clinical trials to test Oxford University’s new vaccine for Covid-19 are “progressing very well”, the head of the Oxford Vaccine Group (OVG) s.UK News: LONDON: Clinical trials to test Oxford University’s new vaccine for Covid-19 are “progressing very well”, the head of the Oxford Vaccine Group (OVG) s.

Oxford vaccine clinical trials are 'going well' - Times of India

AstraZeneca is partnering with University of Oxford to develop and distribute a vaccine being trialled in the UKAstraZeneca is partnering with University of Oxford to develop and distribute a vaccine being trialled in the UK

US provides AstraZeneca with $1 billion for COVID-19 vaccine

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works.

UK to start huge vaccine test; China reports promising hints (Update)

The Oxford trial will monitor the effects on thousands of people's immune systems.The Oxford trial will monitor the effects on thousands of people's immune systems.

Coronavirus: Children and older adults to take part in vaccine trial - BBC News

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 peoplBritish researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 peopl

U.K.'s COVID-19 Study Aims to Vaccinate More Than 10,000 | Hamodia.com

By pledging up to $1.2 billion in assistance, the Department of Health and Human Services has ensured its access to a large supply of the ChAdOx1 nCoV-19 vaccine -- assuming it works.By pledging up to $1.2 billion in assistance, the Department of Health and Human Services has ensured its access to a large supply of the ChAdOx1 nCoV-19 vaccine -- assuming it works.

U.S. Seals Deal with AstraZeneca for 300 Million Doses of Potential Coronavirus Vaccine | The Motley Fool

(Bloomberg) -- The U.S. threw its weight behind one of the fastest-moving experimental solutions to the coronavirus pandemic, pledging as much as $1.2 billion to AstraZeneca Plc to help make the University of Oxford’s Covid vaccine.Beset by criticism of his response to the outbreak, President Donald(Bloomberg) -- The U.S. threw its weight behind one of the fastest-moving experimental solutions to the coronavirus pandemic, pledging as much as $1.2 billion to AstraZeneca Plc to help make the University of Oxford’s Covid vaccine.Beset by criticism of his response to the outbreak, President Donald

U.S. Raises Ante in Vaccine Race With $1.2 Billion for Astra

The London Economic |"That is going to mean a lot of elderly are going to die and those with heart conditions and diabetes and other risk factors.' | NewsThe London Economic |"That is going to mean a lot of elderly are going to die and those with heart conditions and diabetes and other risk factors.' | News

Herd immunity without vaccine or treatment is a 'Darwinian policy'

If and when the vaccine becomes available, the first 400 million doses go to AmericaIf and when the vaccine becomes available, the first 400 million doses go to America

A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal. A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal.

Only days after Moderna reported positive early results for its potential COVID-19 vaccine, AstraZeneca has stolen the spotlight back. On Thursday, the U.K. drug giant scored a $1 billion contribution from the United States for development, production and delivery of its potential shot starting this fall. Only days after Moderna reported positive early results for its potential COVID-19 vaccine, AstraZeneca has stolen the spotlight back. On Thursday, the U.K. drug giant scored a $1 billion contribution from the United States for development, production and delivery of its potential shot starting this fall. 

AstraZeneca scores $1.2B from U.S., signs up to deliver hundreds of millions of COVID-19 vaccines | FiercePharma

The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.

‘America first’: US secures 300 million doses of potential UK COVID-19 vaccine – EURACTIV.com

The coronavirus vaccine race delivers more promising news, as the US invested $1.2 billion to speed up development and secure 300 million doses for the breakthrough Oxford candidate.The coronavirus vaccine race delivers more promising news, as the US invested $1.2 billion to speed up development and secure 300 million doses for the breakthrough Oxford candidate. The novel coro…

US secures 300M doses of coronavirus vaccine candidate from Oxford – BGR

British pharmaceutical company AstraZeneca says it is ready to provide a potential vaccine against the new coronavirus from September.British pharmaceutical company AstraZeneca says it is ready to provide a potential vaccine against the new coronavirus from September.

British firm ready to supply vaccine in September | NHK WORLD-JAPAN News

An update on AstraZeneca’s COVID-19 vaccine candidate, AZD1222, reveals the firm has secured capacity to make one billion doses, with the first deliveries plann

First 400 million COVID-19 vaccine doses earmarked for UK and USA

AstraZeneca plc (NYSE: AZN), which is collaborating with the Oxford University to develop a vaccine for SARS-CoV-2, announced Thursday a funding ...AstraZeneca plc (NYSE: AZN), which is collaborating with the Oxford University to develop a vaccine for SARS-CoV-2, announced Thursday a funding commitment from the U.S....

Astrazeneca PLC (NYSE:AZN) - AstraZeneca Receives Over $1B In BARDA Funding For Coronavirus Vaccine | Benzinga

US secures 300 million. Read more at straitstimes.com.World News -US secures 300 million. Read more at straitstimes.com.

In Brief: US secures 300 million possible vaccine doses, World News & Top Stories - The Straits Times

European pharmaceutical company AstraZeneca said Thursday it has received more than $1 billion from the U.S. government to develop its coronavirus vaccine candidate.European pharmaceutical company AstraZeneca said Thursday it has received more than $1 billion from the U.S. government to develop its coronavirus vaccine candidate.

U.S. gives AstraZeneca $1 billion for COVID-19 vaccine candidate - UPI.com

Britain has the world's second-highest death toll in the coronavirus pandemic, and has faced sustained criticism for its response to the outbreak.Britain has the world's second-highest death toll in the coronavirus pandemic, and has faced sustained criticism for its response to the outbreak.

Virus-stung UK banks on vaccine drive [ARTICLE] - Pulse Nigeria

As states continue to reopen after weeks-long shutdowns shuttered businesses, the number of unemployed Americans continues to rise. On Thursday, the Labor...As states continue to reopen after weeks-long shutdowns shuttered businesses, the number of unemployed Americans continues to rise. On Thursday, the Labor Department announced 2.4 million people sought jobless benefits last week, bringing the total to nearly 39 million in the past two months.

US Virus Updates: CDC Releases Guidelines for ‘Communities of Faith’; Study Sounds Alarm on Malaria Drug – NBC 6 South Florida

404 Not Found

KIDS and over 70s are to trial the Oxford University coronavirus jab. More than 10,200 people – including older adults and five to 12-year-olds – will be included in the second phase of…

Kids and over 70s to trial Oxford Uni coronavirus jab – as scientists aim for first doses this year – The Sun

AstraZeneca has announced a deal to distribute 400 million doses of Oxford Uni's coronavirus vaccine, but the vaccine may not work.AstraZeneca has announced a deal to distribute 400 million doses of Oxford Uni's coronavirus vaccine, but the vaccine may not work.

3 Reasons Why Oxford’s Record-Breaking COVID-19 Vaccine is a Risky Bet

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on ...AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on ...

Drugmaker AstraZeneca to make a billion COVID-19 vaccine doses if tests succeed - CNA

AstraZeneca is also in discussions with the Serum Institute of India and other potential partners to increase production and distribution.AstraZeneca is also in discussions with the Serum Institute of India and other potential partners to increase production and distribution.

AstraZeneca receives $1bn US investment for Oxford vaccine, Health News, ET HealthWorld

Drugmaker says it is capable of producing 1 billion doses of the AZD1222 vaccineDrugmaker says it is capable of producing 1 billion doses of the AZD1222 vaccine

Coronavirus: AstraZeneca ready to supply potential vaccine in September | World – Gulf News

Waterford's Jared Burrows, the winning pitcher in the 2019 Class L state championship game, was named the 2020 Gatorade Connecticut Baseball Player of theThe crowded walls of the place affectionately known as "The X" got more cramped Thursday, a new banner forthcoming even without a spring of high

The Day - Waterford's Burrows named Gatorade Connecticut Baseball Player of the Year - News from southeastern Connecticut

The company says it has secured orders for 400 million doses of the as yet unproven vaccine, to be delivered from this September. The company says it has secured orders for 400 million doses of the as yet unproven vaccine, to be delivered from this September.

AstraZeneca Receives $1 Billion From U.S. Government To Produce Coronavirus Vaccine

Read the latest Granada stories, Liverpool School of Tropical Medicine taking part Covid-19 vaccine trials on ITV News, videos, stories and all the latest Granada newsLiverpool School of Tropical Medicine has begun recruiting frontline health and social care workers to take part in a COVID-19 vaccine trial. The school has been selected as one of the UK sites for phase III of the University of Oxford’s COVID-19 vaccine clinical trial. Led by Professor Andrew Pollard from the Oxford Vaccine Group, the trial will study the efficacy and safety of the candidate COVID-19 vaccine in healthy adults. The team at LSTM, under the leadership of Professor Daniela Ferreira: “We were delighted to be asked by Professor Pollard to be a site for the study. From the vaccine candidates we have in therace against COVID, the Oxford vaccine is progressing at an amazing pace. If the trials demonstrate this vaccine is safe and effective there will be millions of doses already produced that could be quickly administered. The potential impact of this could be massive on two fronts, by saving millions of lives not only in the UK, but also globally, as well as the economic benefits of allowing society to get back to normal without the risk of future COVID-19 peaks.”

Liverpool School of Tropical Medicine taking part Covid-19 vaccine trials | Granada - ITV News

THE United States has secured almost a third of AstraZeneca's one billion possible Covid-19 vaccine doses by pledging up to US$1.2 billion, as the world's biggest powers scramble for medicinal supplies to get their economies back to work. Read more at The Business Times.THE United States has secured almost a third of AstraZeneca's one billion possible Covid-19 vaccine doses by pledging up to US$1.2 billion, as the world's biggest powers scramble for medicinal

US secures 300 million doses of potential Covid-19 vaccine, Government & Economy - THE BUSINESS TIMES

AstraZeneca secures orders for COVID-19 vaccineAstraZeneca secures orders for COVID-19 vaccine

AstraZeneca secures orders for COVID-19 vacci... | Taiwan News

Prasun Sonwalkarletters@hindustantimes.comLondon Days after reports suggested that a promising coronavirus disease (Covid-19) vaccine being developed by the Oxford Vaccine Group...Prasun Sonwalkarletters@hindustantimes.comLondon Days after reports suggested that a promising coronavirus disease (Covid-19) vaccine being developed by the Oxford Vaccine Group...

Oxford vaccine trial progressing ‘very well’, on to Phase II - india news - Hindustan Times

An early trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and effective at prompting an immune response.An early trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and effective at prompting an immune response.

Promising results for potential COVID-19 vaccine to be tested on Canadians | CTV News

"If he retains stock in companies that are investing in the development of a vaccine," said government watchdog CREW, "we can't be confident of the integrity of any process in which he is involved.""If he retains stock in companies that are investing in the development of a vaccine," said government watchdog CREW, "we can't be confident of the integrity of any process in which he is involved."

'This Is My Retirement': Trump's Covid-19 Vaccine Czar Refuses to Sell Stock Holdings of Major Drug Company | Common Dreams News